Search

everythinglearnresearchcommunity

for

Search:↓

Older age, family history, and low iron levels increase the risk of female hair loss.

Alopecia areata and vitiligo share immune system dysfunction but differ in specific immune responses and affected areas.

Adolescents with severe alopecia incur significantly higher healthcare costs.

An 11-year-old child with total hair loss may have a genetic autoimmune disease, and the outlook for hair regrowth is not good.

Platelet-rich plasma therapy is more effective than minoxidil lotion for increasing hair count in men with hair loss, with mild side effects and high satisfaction.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

An 11-year-old girl with compulsive hair pulling was successfully treated with therapy and medication.

Alopecia areata is a complex condition causing hair loss, linked to genetics and immune system issues, and may be related to other autoimmune diseases; treatments vary in effectiveness.

The main causes of diffuse hair loss in women are telogen effluvium and androgenetic alopecia, often related to stress and iron deficiency.

Customized medications made through compounding can be beneficial for various skin conditions but require careful regulation and collaboration between doctors and pharmacists.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Mice with autoimmune hair loss showed signs of heart problems.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

AA patients with comorbid conditions face more severe hair loss and need specific treatments.

People with alopecia areata have a higher risk of depression and anxiety, and often face unemployment and work absences.

The fractional carbon dioxide laser is a safe and effective treatment for alopecia areata and works better than betamethasone valerate cream alone.

Antidepressants might help with skin inflammation and improve conditions like psoriasis and eczema.

Rare ULBP3 gene changes may raise the risk of Alopecia areata, a certain FAS gene deletion could cause a dysfunctional protein in an immune disorder, and having one copy of a specific genetic deletion is okay, but two copies cause sickle cell disease.

Type 1 diabetes often occurs with other autoimmune diseases, and personalized treatment based on genetics can improve outcomes.

Advanced therapies like gene, cell, and tissue engineering show promise for hair regrowth in alopecia, but their safety and effectiveness need more verification.

Alopecia areata leads to significantly higher healthcare costs due to more doctor visits and prescriptions.

Recognizing and treating skin symptoms in essential thrombocythemia is crucial for patient quality of life.

Alcohol-free minoxidil 5% is effective and safe for treating male pattern hair loss.

Polymeric nanoparticles could improve hair loss treatments by delivering drugs more effectively to hair follicles.

Hair usually grows back 1-3 months after treatment for anagen effluvium, and children with Loose Anagen Hair Syndrome often improve by adolescence.

The document concludes that proper diagnosis and evidence-based treatments are crucial for managing hair diseases, and psychological support for patients is important.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

People with Inflammatory Bowel Disease often lose hair due to stress, medication side effects, or lack of nutrients, and treatment depends on the specific cause.

Multiphoton microscopy can non-invasively tell apart scarring from non-scarring hair loss and could aid in treatment.